Phathom Pharmaceuticals, Inc. (PHAT) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to the Fathom Pharmaceutical second quarter 2025 earnings results call. At this time, all participants are on a listen-only mode. After this presentation, there will be a question and answer session. To raise your hand to ask a question, please press star 1-1. To lower your hand, please press star 1-1 again. Please be advised that today's call is being recorded. With that, I'd like to turn the call over to Eric Chiarelli, Fathom's head of investor relations. Please go ahead. Thank you, Operator. Hello everyone and thank you for joining us this morning to discuss VADM's second quarter 2025 results. This morning's presentation will include remarks from Steve Bosta, our President and CEO, and Robert Breedlove, our VP of Finance and Principal Accounting Officer. Just a couple of logistical items before we get started. Earlier this morning, we issued a press release detailing the results we will be discussing during the call. A copy of that press release can be found under the News Releases section of our corporate website. The recording of today's webcast and the slides we'll be reviewing can be found under the events and presentation section of our corporate website. Before we begin, let me remind you that we will be making a number of forward-looking statements throughout today's presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Fathom's control. Actual results may materially differ from the forward-looking statements, and any such risks may materially adversely affect our business and results of operations and the trading prices for Fathom's common stock. A discussion of these statements and risk factors is available on the current Safe Harbor slide, as well as in the risk factors section of our ...